about
Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant diseaseThe biology of small leucine-rich proteoglycans in bone pathophysiologyCollagen VI and hyaluronan: the common role in breast cancerThe roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progressionOccupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review)Data on the putative role of p53 in breast cancer cell adhesion: Technical information for adhesion assayApplication of metabolomics: Focus on the quantification of organic acids in healthy adultsMechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune systemThe motile breast cancer phenotype roles of proteoglycans/glycosaminoglycans.Biological importance of reactive oxygen species in relation to difficulties of treating pathologies involving oxidative stress by exogenous antioxidants.Impact of asynchronous ventricular activation on pro-inflammatory cytokines and oxidative stress in paced patientsVariations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.Impact of multicellular tumor spheroids as an in vivo‑like tumor model on anticancer drug response.Telomerase activity in pregnancy complications (Review).The role of SLRP-proteoglycans in osteosarcoma pathogenesis.Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review).Lumican, a small leucine-rich proteoglycan.Protein bio-corona: critical issue in immune nanotoxicology.Role of oxidative stress in chemical allergens induced skin cells activation.ROS-major mediators of extracellular matrix remodeling during tumor progression.Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response.Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.Heparan sulfate proteoglycans and heparin regulate melanoma cell functions.Hyaluronan/RHAMM interactions in mesenchymal tumor pathogenesis: role of growth factors.Anthracycline-dependent cardiotoxicity and extracellular matrix remodeling.Cancer microenvironment and inflammation: role of hyaluronan.Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axisReceptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.Hyaluronan regulates chemical allergen-induced IL-18 production in human keratinocytes.Syndecans - key regulators of cell signaling and biological functions.HA metabolism in skin homeostasis and inflammatory disease.Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells.Short-term culture of monocytes as an in vitro evaluation system for bionanomaterials designated for medical use.Parathyroid hormone affects the fibroblast growth factor-proteoglycan signaling axis to regulate osteosarcoma cell migration.Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity.Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo.Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes.In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
P50
Q26800001-3D4EB1C4-5BEE-4A81-B429-CDF9A0F66B64Q26861290-C478044D-702F-4788-9C8A-CAD3C574C9EEQ27011319-43EBC1CA-8978-4A67-B15A-6A063DA57034Q27025313-B404AA91-F640-4217-828C-72B9D3BE100EQ28389743-6C7E7FB2-7F3F-4B80-881E-0485E54691D8Q31137353-E6FD7410-4D3D-4F53-B019-50A8330D16CFQ33783924-8A11FA3D-1966-4ED0-B3ED-DEB260D90C61Q33831191-84317302-97A9-4A59-9E0E-D3678695B05DQ34031745-E934A43F-BDF7-42DB-A468-538F76B89756Q34985279-134DAC4B-22A0-4C74-8ED6-0049AB9D21CDQ35584311-7CD2D2DC-FC93-482B-8944-3E57804FB4C7Q36825423-F794A48B-F0AE-4FE0-A2AF-3E26C95429D4Q36903596-4DC4250D-5E2C-4D44-9F42-D9389BDBCC94Q37032233-1BFF0F58-CD47-48D8-858D-C18DF42FA1E4Q37228598-BEB69EF6-529B-4CD7-9D33-E101AE0B7881Q37255459-019BE030-BC91-47C5-93D7-8371E955AA0DQ37307767-9DC165C4-2298-48BB-9E20-C575849DE2D3Q37651354-21A0EABA-4F8B-460D-86B8-D7FDFA4F7E46Q38085934-29B79BA9-01CE-4957-AFDD-E890EBE495A0Q38116287-C4C14B2B-9A8E-4901-9E23-A0EE2D0B8A08Q38141480-42E39EAD-1ECD-41B9-80F1-1FB8C62925C4Q38142400-2E64CD0B-9DA7-444F-987B-702192CF51D6Q38184224-1FB70BEE-579B-4C0A-86D8-590121517AD7Q38235804-7F3031D9-E7F4-44FB-86DF-14D068A0C5DCQ38257378-CBE54FBA-F24E-47F3-BA63-CCCB1D5B91ECQ38450763-7FAB72E3-F1BD-4155-8B73-83C3F77DF321Q38737938-4C0A0D76-CC31-46C1-AE4D-CE2881F82412Q38798169-B2C9E514-EE6F-4C38-886F-D3E371898518Q38950792-20D03A7F-272D-4186-9395-FB3FE981AF33Q38993457-DA0226E2-29D1-4F70-B60F-525563744FD6Q39097601-0DF65BD5-8616-4B5C-83DE-7A82A9181CC7Q39214677-2C405B67-0944-49BA-A902-BE215BAE05A4Q39460343-4664025F-95C6-4456-BC7B-0256F6F75D4BQ39491673-E102F879-A1A5-4192-931F-140A1823B018Q39573413-985C92A3-0575-4CCF-AB80-4474D6BE99A2Q39785077-21D7320A-5431-4228-9DFA-7023D3AF8C05Q39901293-74482523-C74E-44D0-93D4-6CD966B73BBFQ40134887-191463EC-C1B2-4F6D-9332-31851A08C1A9Q40218355-07F5F99A-60F2-4924-B4E9-2C6683056DE8Q40677276-9CE00D74-94AD-4E9E-AB33-8D3C2DB80824
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dragana Nikitovic
@ast
Dragana Nikitovic
@en
Dragana Nikitovic
@es
Dragana Nikitovic
@nl
Dragana Nikitovic
@sl
type
label
Dragana Nikitovic
@ast
Dragana Nikitovic
@en
Dragana Nikitovic
@es
Dragana Nikitovic
@nl
Dragana Nikitovic
@sl
prefLabel
Dragana Nikitovic
@ast
Dragana Nikitovic
@en
Dragana Nikitovic
@es
Dragana Nikitovic
@nl
Dragana Nikitovic
@sl
P106
P1153
6505773521
P21
P31
P3835
dragana-nikitovic
P496
0000-0003-3882-7399